Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Biogen introduces Avonex in first market

May 24, 1996

ICN will market fluoxetine in Russia, ex-Yugoslavia

May 24, 1996

Fujisawa, Nihon Shokubai claim CCK-B antagonists

May 24, 1996

ADIR claims melatonin receptor ligands for CNS disorders

May 24, 1996

Ultiva okayed for marketing in Germany; U.S. approval recommended by committee

May 24, 1996

Rizatriptan NDA filing expected in mid-1997

May 24, 1996

L-742694: Morpholine-based NK1 antagonist

May 24, 1996

CP-122721 shows potent affinity for NK1 receptors after oral dosing

May 24, 1996

Myotrophin up for advisory committee review

May 17, 1996

Memantine to be tested in AIDS-related dementia, painful peripheral neuropathies

May 17, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...